Valuation dashboard for Accuray Incorporated (ARAY) with P/E N/A, P/B 0.67, EV/EBITDA -12.16 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region.
Analysis Summary
Accuray Incorporated reported revenue of $401.9M in the most recent fiscal year, growing at a 5-year CAGR of 0.3%.
Trailing-twelve-month margins: gross margin 27.7%, operating margin -6.6%, net margin -12.2%.
At the current price of $0.23, ARAY has negative trailing earnings (P/E not meaningful) and an ROE of -99.04%. Market capitalisation stands at $28M.
Balance sheet quality for ARAY: current ratio of 1.5. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.67 |
| EV / EBITDA | -12.16 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| ARAY | Accuray Incorporated | $28M | 0.67 | -99.0% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 29.27 | 4.55 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $66.5B | 48.91 | 5.86 | 11.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $0.23 |
| Market Cap | $28M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -99.04% |
| Return on Invested Capital | -10.09% |
| Return on Assets | -11.09% |
| Gross Margin | 27.73% |
| Operating Margin | -6.58% |
| Net Margin | -12.24% |
Related companies: ANIK · AVR · LNSR · MIST · MXCT · OWLT · PROF
Explore sector: Healthcare · Medical - Devices
More sections of ARAY: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks